Altimmune
ALT
ALT
120 hedge funds and large institutions have $125M invested in Altimmune in 2023 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 38 increasing their positions, 32 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
26% less first-time investments, than exits
New positions opened: 31 | Existing positions closed: 42
39% less capital invested
Capital invested by funds: $205M → $125M (-$80.8M)
Holders
120
Holding in Top 10
–
Calls
$2.04M
Puts
$997K
Top Buyers
| 1 | +$8.01M | |
| 2 | +$2.71M | |
| 3 | +$1.78M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.72M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$1.63M |
Top Sellers
| 1 | -$14.7M | |
| 2 | -$6.05M | |
| 3 | -$5.87M | |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
-$2.86M |
| 5 |
Goldman Sachs
New York
|
-$2.41M |